Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N06AA08
CAS registry number (Chemical Abstracts Service)
0004498-32-2
Chemical Formula
C18-H21-N3-O
Molecular Weight
295
Therapeutic Category
Antidepressant, tricyclic
Chemical Name
11H-Dibenzo[b,e][1,4]diazepin-11-one, 10-[2-(dimethylamino)ethyl]-5,10-dihydro-5-methyl-
Foreign Names
- Dibenzepinum (Latin)
- Dibenzepin (German)
- Dibenzépine (French)
- Dibencepina (Spanish)
Generic Names
- Dibencepina (OS: DCIT)
- Dibenzepin (OS: BAN)
- Dibenzépine (OS: DCF)
- LW 1927 (IS)
- Dibenzepine Hydrochloride (OS: USAN)
- HF 1927 (IS: Sandoz)
Brand Names
- Noveril retard
Novartis, Austria - Noveril
Novartis, Switzerland; Novartis, Czech Republic; Novartis, Hungary; Novartis, Israel; Novartis, Luxembourg; Novartis, Poland; Novartis, Slovakia
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment